Peruvian President Hugo sagasti announced in a televised speech to the whole country on the 6th that Peru has reached an agreement with Sinopharm to purchase the new inactivated coronavirus vaccine produced by the group, and the first 1 million doses of the vaccine will arrive in Peru this month.Sagasti also said that the phase III clinical trial of Xinguan inactivated vaccine conducted by Sinopharm in Peru showed the effectiveness of the vaccine.
Sagasti also announced that Peru also signed a contract with British AstraZeneca pharmaceutical company to purchase the new crown vaccine on the 6th. Under the contract, AstraZeneca will provide 14 million doses of the vaccine from September this year.
Novel coronavirus pneumonia confirmed on the day of the new day, 960 cases were confirmed in Peru, and 1022018 cases were confirmed by the 5 day of the new crown pneumonia, 52 new deaths and 37925 deaths were reported.
Novel coronavirus pneumonia outbreaks in Peru since early March 2020 have been closely cooperated with China and Peru. China is the first country to donate medical supplies and equipment to Peru, and has sent a medical team to share experience. In early September last year, Sinopharm's new crown vaccine clinical trial team arrived in Peru to conduct clinical trials in cooperation with the University of Cayetano eredia and the National University of San Marcos in Peru. These trials have proved the effectiveness of the vaccine.